Hemostasis News and Research RSS Feed - Hemostasis News and Research

Hemostasis or haemostasis is a complex process which causes the bleeding process to stop. Most times this includes the changing of blood from a fluid to a solid state. Intact blood vessels are central to moderating blood's tendency to clot.
Research report on global electrosurgical market

Research report on global electrosurgical market

Research and Markets has announced the addition of the "Electro Surgical Market" report to their offering. [More]
New market research report on Canadian endoscopic and surgical devices market

New market research report on Canadian endoscopic and surgical devices market

Reportlinker.com announces that a new market research report is available in its catalogue: Canadian Endoscopic and Surgical Devices Market. [More]
Research findings suggest new therapeutic strategy for intracerebral hemorrhage

Research findings suggest new therapeutic strategy for intracerebral hemorrhage

Intracerebral hemorrhage is a type of stroke that affects two million people worldwide each year. Despite its seriousness, no effective treatment has yet been developed. But if a recent study in the journal Nanomedicine is right, good news for doctors and patients might one day arrive in a very small package: namely, a "peptide nanofiber scaffold." [More]
Members of JUGGLE network collaborate to improve project coordination

Members of JUGGLE network collaborate to improve project coordination

The field of life sciences is at the crossroads of biology and medicine and is a key component of the research portfolio of Johannes Gutenberg University Mainz (JGU). [More]
Cancer drug offers protection against thrombosis

Cancer drug offers protection against thrombosis

Case Western Reserve University researchers have discovered that an existing drug used to help cancer patients has the potential to protect thousands of others from the often-deadly impact of vascular clots. [More]
Cook Medical's Instinct Endoscopic Hemoclip now available to gastroenterologists

Cook Medical's Instinct Endoscopic Hemoclip now available to gastroenterologists

The Instinct Endoscopic Hemoclip is now available to gastroenterologists in major global markets. The clip is used to stop gastrointestinal (GI) tract bleeding, which is a condition that can be challenging to treat because of the variations among bleeds. [More]
Researcher develops synthetic hydrogel that promotes natural clotting, heals surgical wounds

Researcher develops synthetic hydrogel that promotes natural clotting, heals surgical wounds

Synthetic collagen invented at Rice University may help wounds heal by directing the natural clotting of blood. [More]
FDA allows CryoLife to begin PerClot clinical trial in the U.S.

FDA allows CryoLife to begin PerClot clinical trial in the U.S.

CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that it has received approval of its Investigational Device Exemption (IDE) for PerClot from the United States Food and Drug Administration. [More]
Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Scientists discover how MRP-14 gene generates dangerous clots that could trigger heart attack

Right now, options are limited for preventing heart attacks. However, the day may come when treatments target the heart attack gene, myeloid related protein-14 (MRP-14, also known as S100A9) and defang its ability to produce heart attack-inducing blood clots, a process referred to as thrombosis. [More]
rEVO Biologics commences ATryn Phase 3 clinical program for treatment of preeclampsia in pregnant women

rEVO Biologics commences ATryn Phase 3 clinical program for treatment of preeclampsia in pregnant women

rEVO Biologics Inc., a subsidiary of LFB SA, today announced the initiation of the Phase 3 clinical program for ATryn for the treatment of preeclampsia in pregnant women during the 24th to 28th week of pregnancy. [More]
SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

SEATTLE II study confirms safety and efficacy of thrombolytic therapy for acute PE

EKOS Corporation, a BTG International group company, notes the presentation of the results of the SEATTLE II trial this afternoon at ACC.14, the 63rd Annual Scientific Session and Exposition of the American College of Cardiology in Washington, DC in the United States. [More]
AccessClosure commercially launches Mynx Ace Vascular Closure Device

AccessClosure commercially launches Mynx Ace Vascular Closure Device

AccessClosure Inc., the market leader in extravascular care technology, has commercially launched its Mynx Ace Vascular Closure Device, a safe and secure vascular closure product that provides consistent results with a new, easy-to-use deployment system to seal femoral artery access sites. [More]
Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. [More]
LFB SA initiates Phase 3 program for human Factor VIIa in patients with congenital hemophilia

LFB SA initiates Phase 3 program for human Factor VIIa in patients with congenital hemophilia

LFB SA, through its rEVO Biologics subsidiary, announced today initiation of the global Phase 3 program for LR769, a novel recombinant form of human Factor VIIa, in patients with congenital hemophilia A or B with inhibitors. [More]

New hemostasis valve with sideport tubing and stopcock launched by Qosina

... [More]
T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

T2HemoStat detection of novel clot behavior could direct therapeutic choices for stroke, heart attack victims

​T2 Biosystems, a company developing direct detection products enabling superior diagnostics, announced that scientists from the University of Pennsylvania and T2 Biosystems have published a paper in Blood describing novel clot structure biology detected while testing T2 Bio's T2HemoStat-. [More]

Qosina announces addition of new Control Stroke Syringes

Qosina is pleased to announce the addition of five new Control Stroke Syringes. These syringes help ensure volume regulation during fluid delivery, and are used for precise injection or withdrawal. All syringes are equipped with a dimple inside the barrel opposite the graduation, which acts as a plunger stop. [More]
Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

Late-breaking abstracts on treatment of blood cancers and bleeding disorders presented at ASH meeting

A range of studies highlighting late-breaking research advances in the understanding and treatment of blood cancers and bleeding disorders are being presented today during the 55th American Society of Hematology Annual Meeting and Exposition in New Orleans. [More]
Alnylam presents new pre-clinical data with ALN-AT3 for treatment of hemophilia and RBD

Alnylam presents new pre-clinical data with ALN-AT3 for treatment of hemophilia and RBD

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has presented new pre-clinical data with ALN-AT3, a subcutaneously administered RNAi therapeutic targeting antithrombin (AT) for the treatment of hemophilia and rare bleeding disorders (RBD), at the 55th Annual Meeting of the American Society of Hematology (ASH) held December 7 - 10, 2013 in New Orleans. [More]

New Torquers announced by Qosina

Qosina is pleased to announce the addition of three new Torquers, #97344 for use with guide wires 0.008 inch - 0.018 inch (0.20 mm - 0.46 mm, 0.6 FR - 1.4 FR) and #97345 or #97346 which fit 0.014 inch - 0.038 inch (0.36 mm - 0.96 mm, 1.1 FR - 3 FR). Torquer #97346 has a narrow profile design which is smaller and lighter than the other two. [More]